SAN FRANCISCO — Drug companies here are rallying behind legislation that they say would fix a state consumer privacy law that threatens to jeopardize the integrity of clinical trial results and drive scientists out of California.

The bill, called SB-1121, would prevent patients from accessing and deleting some of their data from clinical trials. The idea is to make sure that clinical trial participants can’t use the consumer privacy law to prohibit their data from being used by researchers, or to find out if, say, they’re receiving an active treatment or a placebo.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • This makes little sense.
    One of the very fundamental premises in human subject research is the subjects’ option to withdraw at any time and, likewise, to have their data expunged upon withdrawal.
    Why would CA want to pass a law that violates the foundations of protecting humans in a research environment? These rules and regulations are there to prevent negative effects on subjects and are part of the premise of weighing potential harm versus potential gain…and the ability to drop out and have your data expunged when you have left the study is an iomportant component in the subjects’ perception of well-being and trust in researchers

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy